TY  - JOUR
T1  - BRonchiolitis—reply
AU  - Mull CC, Scarfone RJ
Y1  - 2004/07/01
N1  - 10.1001/archpedi.158.7.707-b
JO  - Archives of Pediatrics & Adolescent Medicine
SP  - 707
EP  - 707
VL  - 158
IS  - 7
N2  - 
Our decision to compare epinephrine with albuterol was based on our clinical observation that a substantial proportion of infants moderately ill with bronchiolitis responds favorably to bronchodilators. This proportion was appreciated to be high enough that we felt it unjustified to deny therapy to a placebo group. In light of the Menon et al1 study, our goal was to clarify the role of epinephrine in comparison with albuterol in the treatment of such infants. At the time that this study was conducted, the standard of care for these patients at our institution included provision of a trial of nebulized albuterol. As such, the hospital's institutional review board would not have approved a placebo study.

SN  - 1072-4710
M3  - doi: 10.1001/archpedi.158.7.707-b
UR  - http://dx.doi.org/10.1001/archpedi.158.7.707-b
ER  -